Effect of Highly Active Antiretroviral Therapy on Survival in Patients With AIDS-Associated Pulmonary Kaposi’s Sarcoma Treated With Chemotherapy

Kaposi's sarcoma (KS) is the most common AIDS-related malignancy. Pulmonary involvement by KS (PKS) has carried a poor prognosis with median reported survival ranging from 3 to 10 months. We studied whether the introduction of highly active antiretroviral therapy (HAART; triple antiretroviral t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2001-09, Vol.19 (18), p.3848-3851
Hauptverfasser:	HOLKOVA, Beata, TAKESHITA, Kenichi, CHENG, Debbie M, VOLM, Matthew, WASSERHEIT, Carolyn, DEMOPOULOS, Rita, CHANAN-KHAN, Asher
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired Immunodeficiency Syndrome - complications Adult Antineoplastic agents Antiretroviral Therapy, Highly Active Biological and medical sciences Chemotherapy Ethnic Groups Humans Lung Neoplasms - complications Lung Neoplasms - drug therapy Medical sciences Middle Aged Multivariate Analysis Pharmacology. Drug treatments Registries Retrospective Studies Sarcoma, Kaposi - complications Sarcoma, Kaposi - drug therapy Survival Analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!